![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS MULTINODULAR GOITER
Minerva Endocrinologica 2010 September;35(3):153-9
Copyright © 2010 EDIZIONI MINERVA MEDICA
language: English
Diagnostic imaging work up in multi-nodular goiter
Luster M. 1, Verburg F. A. 2, Scheidhauer K. 3 ✉
1 Department of Nuclear Medicine, University of Ulm, Ulm, Germany; 2 Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany; 3 Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München,Munich, Germany
Ultrasound, scintigraphy and sonographically guided fine-needle biopsy are the cornerstones in the diagnostic work-up multinodular goitre. Subsequent decisions for adequate treatments should be based on accurate tests to avoid unnecessary intervention. Especially in areas with endemic goitre a preselection of patients for the most effective procedure e.g. surgical or medical treatment is mandatory. Autoimmune hyperthyroidism (Graves’ disease), solitary hyperfunctioning thyroid nodules and toxic multinodular goitre (Plummer’s disease) constitute a clear indication for radioiodine treatment in many cases. Recently, there is an emerging role for I-131 in the treatment for so called subclinical hyperthyroidism caused by either of three first entities and for patients with non-toxic goitre, in whom surgery is not an option. These patients with large non toxic goitre encompass a group of patients who are euthyroid but may benefit from diminishment of thyroid volume. We review the spectrum of diagnostic tests and provide some recommendations regarding (nuclear medicine) therapy.